3billion Showcases AI Genomic Interpretation SaaS at AWS Public Sector Day 2025

Seoul, South Korea – September 12, 2025 – 3billion Inc. (CEO: Changwon Keum), a leading AI-powered rare disease diagnosis company, announced that its Chief Information Officer (CIO), Se Hwan Kim, presented the company’s AI genomic interpretation SaaS case study at AWS Public Sector Day 2025 on September 11 at the Korea Chamber of Commerce and Industry.

Accelerating Rare Disease Diagnosis with Cloud-Based AI

At the event, 3billion highlighted how its proprietary AI variant interpretation software, GEBRA™, processes 100–200 GB of whole genome data per patient quickly and accurately. By leveraging AWS infrastructure, 3billion built a scalable, secure, and high-performance SaaS platform that enables physicians worldwide to deliver faster, standardized rare disease diagnoses without additional hardware or system setup.

AWS Public Sector Day is a global event where experts from public institutions, healthcare, education, and research gather to share digital transformation success stories powered by cloud and AI technologies.

Building Secure, Scalable Genomic SaaS with AWS

During his session, CIO Kim shared insights on:

• High-volume genome data processing: Efficiently analyzing massive whole genome datasets.
• SaaS transformation of GEBRA: Turning in-house genomic interpretation into a cloud-native platform.
• Governance and compliance: Meeting international healthcare data security and privacy standards.
• Scalable infrastructure: Designing a robust system architecture to support global users.

These best practices attracted strong interest from healthcare and research professionals looking to adopt cloud-driven innovation.

GEBRA: Cloud-Native AI Genomic Interpretation Software

Launched in April 2025, GEBRA™ is 3billion’s proprietary AI-powered variant interpretation software that identifies disease-causing variants from millions of genomic data points and generates clinical-grade reports. Currently used in 12 countries worldwide, GEBRA is available as a cloud-based SaaS platform, enabling healthcare providers to access rapid, standardized genomic interpretation without additional infrastructure investment.

CIO Kim emphasized:

“Through our collaboration with AWS, we successfully built a global software platform capable of interpreting large-scale genome data with speed and precision. We hope our experience provides valuable insights for digital innovation in healthcare and the public sector.”